Esther Heijnen

2.9k citations

49 papers · 2.0k indexed · 2 hit papers · h-index 22

Reproductive Medicine top 0.5%
- Ovarian function and disorders 16
- Reproductive Health and Technologies 13
Pediatrics, Perinatology and Child Health top 1%
- Assisted Reproductive Technology and Twin Pregnancy 14
Public Health, Environmental and Occupational Health top 2%
Infectious Diseases top 5%
- Viral gastroenteritis research and epidemiology 9
Epidemiology top 5%
- Respiratory viral infections research 30
- Influenza Virus Research Studies 13
- Pneumonia and Respiratory Infections 6
Cardiology and Cardiovascular Medicine
- Viral Infections and Immunology Research 6

Co-authors: Marinus J.C. Eijkemans N.S. Macklon Bart C.J.M. Fauser Cora de Klerk Frank J. Broekmans M.F.G. Verberg Edward G. Hughes Joop S.E. Laven
Cited by: Reproductive Medicine Pediatrics, Perinatology and Child Health Public Health, Environmental and Occupational Health
Journals: New England Journal of Medicine (1 paper)The Lancet (1 paper)Journal of Virology (1 paper)
Partner nations: Netherlands United States Belgium

In The Last Decade

Esther Heijnen

48 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Esther Heijnen

Since Specialization

Citations

This map shows the geographic impact of Esther Heijnen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Heijnen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Heijnen more than expected).

Fields of papers citing papers by Esther Heijnen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Heijnen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Heijnen. The network helps show where Esther Heijnen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Esther Heijnen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Esther Heijnen Line = papers co-authored together Esther Heijnen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Phase 3 study of an Ad26.RSV.preF/RSV preF protein vaccine to evaluate the prevention efficacy of RSV-mediated lower tract disease, immunogenicity and safety in Japanese adults Respiratory Investigation ·Hiroshi Tamura,Atsushi Momose,Yumi Takato,Zheng Richuan,Arangassery Rosemary Bastian,Benoît Callendret,Esther Heijnen	2025	0
2	Safety and immunogenicity of the Ad26/protein preF RSV vaccine in adults aged 18 to 59 years with and without at-risk comorbidities for severe respiratory syncytial virus disease: A phase 3, randomized, controlled, immunobridging trial Vaccine ·Archana Jastorff,Efi Gymnopoulou,José A. Salas,Elizabeth Merrall,Erik Buntinx,Charlotte Martin,Helena H. Askling,Isabelle Schenkenberger,A. Yuste,William B. Smith,Rodolfo Sotolongo,Charlotte von Engelhardt,Arangassery Rosemary Bastian,Christy Comeaux,Nynke Ligtenberg,Benoît Callendret,Esther Heijnen	2024	4
3	Immunogenicity and safety of different dose levels of Ad26.RSV.preF/RSV preF protein vaccine in adults aged 60 years and older: A randomized, double-blind, placebo-controlled, phase 2a study Vaccine ·Roy van Heesbeen,Arangassery Rosemary Bastian,Edmund Omoruyi,Jeffrey B. Rosen,Christy Comeaux,Benoît Callendret,Esther Heijnen	2024	3
4	A Phase 1/2a Study Evaluating Safety and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers Aged 12–24 Months Open Forum Infectious Diseases ·Joanne M. Langley,Terry Nolan,Mika Rämet,Peter Richmond,Nelson Augusto Rosário Filho,Wouter Haazen,S Berg,Kristi L. Williams,Arangassery Rosemary Bastian,Edmund Omoruyi,Joanna Williams Durkin,Nadine C. Salisch,Gunter van Geet,Wilbert van Duijnhoven,Esther Heijnen,Benoît Callendret	2024	2
5	Concomitant Administration of Ad26.RSV.preF/RSV preF Protein Vaccine and High-Dose Influenza Vaccine in Adults 65 Years and Older: A Noninferiority Trial The Journal of Infectious Diseases ·Widagdo Widagdo,Arangassery Rosemary Bastian,Archana Jastorff,Ilse Scheys,Els De Paepe,Christy Comeaux,Nynke Ligtenberg,Benoît Callendret,Esther Heijnen	2023	5
6	Evaluation of symptoms in respiratory syncytial virus infection in adults: psychometric evaluation of the Respiratory Infection Intensity and Impact Questionnaire™ symptom scores Journal of Patient-Reported Outcomes ·Richard H. Osborne,Lauren Nelson,Sheri Fehnel,Nicole Williams,Randall H. Bender,Ryan Ziemiecki,Efi Gymnopoulou,Els De Paepe,Yannick Vandendijck,Lindsey Norcross,Esther Heijnen,Gabriela Ispas,Christy Comeaux,Benoît Callendret,Eric K. H. Chan,Jane Scott	2023	5
7	Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countriesbreakdown → European Respiratory Review ·Jonathan S. Nguyen‐Van‐Tam,Maureen A. O’Leary,Emily T. Martin,Esther Heijnen,Benoît Callendret,Roman Fleischhackl,Christy Comeaux,Thao Mai Phuong Tran,Karin Weber	2022	127
8	Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children International Journal of Infectious Diseases ·Sanjay S. Patel,Svetlana Bizjajeva,Kelly Lindert,Esther Heijnen,Janine Oberyé	2019	10
9	MF59-adjuvanted seasonal trivalent inactivated influenza vaccine: Safety and immunogenicity in young children at risk of influenza complications International Journal of Infectious Diseases ·Sanjay S. Patel,Svetlana Bizjajeva,Esther Heijnen,Janine Oberyé	2019	9
10	Immunogenicity of aIIV3, MF59-adjuvanted seasonal trivalent influenza vaccine, in older adults ≥65 years of age: Meta-analysis of cumulative clinical experience International Journal of Infectious Diseases ·Uwe Nicolay,Esther Heijnen,Pantaleo Nacci,P. Patriarca,Brett Leav	2019	35
11	Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial The Lancet Respiratory Medicine ·Timo Vesikari,Judith L. Kirstein,Grace Devota Go,Brett Leav,Mary Ellen Ruzycky,Leah Isakov,Marianne de Bruijn,Janine Oberyé,Esther Heijnen	2018	47
12	A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates Gynecological Endocrinology ·Jie Qiao,Guangxiu Lu,H. W. Zhang,Hua Chen,Caihong Ma,Jan I. Olofsson,Han Witjes,Esther Heijnen,Bernadette Mannaerts	2012	18
13	The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis Human Reproduction Update ·M.F.G. Verberg,Marinus J.C. Eijkemans,N.S. Macklon,Esther Heijnen,Esther B. Baart,Femke Hohmann,Bart C.J.M. Fauser,Frank J. Broekmans	2008	154
14	Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint Human Reproduction ·Suzanne Polinder,Esther Heijnen,N.S. Macklon,J. D. F. Habbema,Bart Fauser,Marinus J.C. Eijkemans	2007	61
15	Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF Human Reproduction ·M.F.G. Verberg,Marinus J.C. Eijkemans,N.S. Macklon,Esther Heijnen,Bart C.J.M. Fauser,Frank J. Broekmans	2007	24
16	The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy Human Reproduction ·Cora de Klerk,Nicholas S. Macklon,Esther Heijnen,Marinus J.C. Eijkemans,Bart C.J.M. Fauser,Jan Passchier,J. A. M. Hunfeld	2007	61
17	A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial The Lancet ·Esther Heijnen,Marinus J.C. Eijkemans,Cora de Klerk,Suzanne Polinder,Nicole G.M. Beckers,Ellen R Klinkert,Frank J. Broekmans,Jan Passchier,Egbert R. te Velde,Nick Macklon,Bart C.J.M. Fauser	2007	220
18	A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome Human Reproduction Update ·Esther Heijnen,Marinus J.C. Eijkemans,Edward G. Hughes,Joop S.E. Laven,N.S. Macklon,Bart C.J.M. Fauser	2005	267
19	The psychological impact of mild ovarian stimulation combined with single embryo transfer compared with conventional IVF Human Reproduction ·Cora de Klerk,Esther Heijnen,N.S. Macklon,H.J. Duivenvoorden,Bart C.J.M. Fauser,Jan Passchier,J. A. M. Hunfeld	2005	44
20	What is the most relevant standard of success in assisted reproduction?: The next step to improving outcomes of IVF: consider the whole treatment Human Reproduction ·Esther Heijnen	2004	78

About Esther Heijnen

Esther Heijnen is a scholar working on Reproductive Medicine, Epidemiology and Pediatrics, Perinatology and Child Health, having authored 49 papers that have together received 2.0k indexed citations. Recurring topics across this work include Respiratory viral infections research (30 papers), Ovarian function and disorders (16 papers), Assisted Reproductive Technology and Twin Pregnancy (14 papers), Influenza Virus Research Studies (13 papers), Reproductive Health and Technologies (13 papers), Viral gastroenteritis research and epidemiology (9 papers), Pneumonia and Respiratory Infections (6 papers) and Viral Infections and Immunology Research (6 papers). The work is most often cited by research in Reproductive Medicine (1.2k citations), Pediatrics, Perinatology and Child Health (874 citations) and Public Health, Environmental and Occupational Health (804 citations). Esther Heijnen has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Marinus J.C. Eijkemans, N.S. Macklon, Bart C.J.M. Fauser, Cora de Klerk, Frank J. Broekmans, Bart C.J.M. Fauser, M.F.G. Verberg, Edward G. Hughes, Joop S.E. Laven and Jan Passchier. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact